EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches

Sumin Hong, Eunjung Han, Saemi Park, Kyungtae Hyun iD, Yunkyoung Lee, Hyun Woo Baek, Hwee-Jin Kim, Yoon Chan Rah, June Choi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sumin Hong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea. Hauptthemen laut MEDLINE: Gentamicins, Ototoxicity, Protective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea University Grants, Basic Science Research Program through the National Research Foundation of Korea, the Korea Environment Industry & Technology Institute (KEITI) through the Technology Devel-opment Project for Safety Management of Household Chemical Products,….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gentamicin-induced ototoxicity leads to irreversible sensorineural hearing loss due to structural and functional damage to inner ear hair cells. In this study, we identified (-)-butaclamol as a potent protective agent against gentamicin-induced cytotoxicity through high-content screening (HCS) of a natural compound library. (-)-Butaclamol significantly enhanced cell viability in both HEI-OC1 cells and zebrafish neuromasts, demonstrating robust protection against gentamicin toxicity. Mechanistically, (-)-butaclamol inhibited intrinsic apoptosis, as evidenced by reduced TUNEL-positive cell counts and the downregulation of BAX and caspase-3, alongside the upregulation of BCL-2. Moreover, (-)-butaclamol activated key survival signaling pathways, including AKT/mTOR and ERK, while suppressing the inflammatory regulator NF-κB. Additional analyses revealed that (-)-butaclamol effectively mitigated oxidative stress and restored autophagic activity, as confirmed by CellROX and LysoTracker assays. Notably, TMRE staining showed that (-)-butaclamol preserved mitochondrial membrane potential in zebrafish hair cells, indicating mitochondrial protection. Collectively, these findings suggest that (-)-butaclamol exerts comprehensive cytoprotective effects against gentamicin-induced ototoxicity by modulating apoptosis, enhancing survival signaling, and restoring mitochondrial and cellular homeostasis. These results highlight the therapeutic potential of (-)-butaclamol and provide a foundation for future studies aimed at its clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GentamicinsOtotoxicityProtective AgentsAnimalsZebrafishApoptosisOxidative StressCell SurvivalMembrane Potential, MitochondrialCell LineHumansSignal TransductionHair Cells, AuditoryAutophagy

Stichwörter der Autor:innen

(-)-butaclamolgentamicinhair cellin vitroin vivoototoxicity

Substanzen

GentamicinsProtective Agents

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea.
  • Laboratory of Otorhinolaryngology-Head & Neck Surgery, Graduate School of Medicine, Korea University, Seoul 02841, Republic of Korea.
  • Biomedical Research Center, Korea University College of Medicine, Ansan Hospital, Ansan-si 15355, Republic of Korea.
  • Zebrafish Translational Medical Research Center, Korea University, Seoul 02841, Republic of Korea.
  • Rare and Intractable Disease Research Group, Korea University, Ansan Hospital, Ansan-si 15355, Republic of Korea.

ORCID-Profile: Kyungtae Hyun, June Choi

Förderung

  • the Korea University Grants
  • Basic Science Research Program through the National Research Foundation of Korea
  • the Korea Environment Industry & Technology Institute (KEITI) through the Technology Devel-opment Project for Safety Management of Household Chemical Products,…
  • Ansan-Si hidden champion fostering and supporting project funded by Ansan city
  • the Korea Medical Device Development Fund funded by the Korean government (Ministry of Science and ICT, Industry and Energy, Health & Welfare, and Food and Dru…
  • Korea University Grants
  • Basic Science Research Program
  • Korea Environment Industry & Technology Institute (KEITI)

Zitieren

APA

Hong, S., Han, E., Park, S., Hyun, K., Lee, Y., Baek, H. W., Kim, H. J., Rah, Y. C., & Choi, J. (2025). Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094201

Vancouver

Hong S, Han E, Park S, Hyun K, Lee Y, Baek HW, et al. Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094201

BibTeX
@article{Hong2025,
  author = {Hong, Sumin and Han, Eunjung and Park, Saemi and Hyun, Kyungtae and Lee, Yunkyoung and Baek, Hyun Woo and Kim, Hwee-Jin and Rah, Yoon Chan and Choi, June},
  title = {Protective Effects of (-)-Butaclamol Against Gentamicin-Induced Ototoxicity: In Vivo and In Vitro Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094201}
}
Kostenlos starten →